HSPA5 is overexpressed in at least 14 types of cancers, including cholangiocarcinoma [99], colon adenocarcinoma, lymphoid neoplasm diffuse large B-cell lymphoma, esophageal carcinoma, glioblastoma, lower-grade glioma, pancreatic adenocarcinoma, prostate adenocarcinoma, rectum adenocarcinoma, skin cutaneous melanoma, stomach adenocarcinoma, thymoma, uterine corpus endometrial carcinoma, and uterine carcinosarcoma. Here, HSPA5 is linked to cancer.